Current and Emerging Approaches for Hepatic Fibrosis Treatment
Liver fibrosis resulting from chronic liver injury is a key factor to develop liver cirrhosis and risk of hepatocellular carcinoma (HCC) which are major health burden worldwide. Therefore, it is necessary for antifibrotic therapies to prevent chronic liver disease progression and HCC development. Th...
Saved in:
| Main Authors: | Jingguo Li, Biguang Tuo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2021/6612892 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The acidic microenvironment in the perisinusoidal space critically determines bile salt-induced activation of hepatic stellate cells
by: Jingguo Li, et al.
Published: (2024-11-01) -
Emerging Epigenetic Therapies for the Treatment of Cardiac Fibrosis
by: Nerea Garitano, et al.
Published: (2025-05-01) -
Current Understanding of Pulmonary Fibrosis: Pathogenesis, Diagnosis, and Therapeutic Approaches
by: Dinglu Cui, et al.
Published: (2025-01-01) -
Emerging therapies for the treatment of hepatitis C
by: Christian M Lange, et al.
Published: (2013-09-01) -
Congenital hepatic fibrosis in Turkish children
by: N Koçak, et al.
Published: (1986-07-01)